Peter Vozzo | Westwicke, Investor Relations |
Jack Khattar | Chief Executive Officer |
Tim Dec | Chief Financial Officer |
David Amsellem | Piper Sandler |
Ken Cacciatore | Cowen |
Good afternoon and welcome to Supernus Pharmaceuticals' Second Quarter 2022 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of ICR Westwicke, Investor Relations representative for Supernus Pharmaceuticals.
You may begin.
Thank you, Jason.